Biotech Stock Roundup: TERN, SMMT Stocks Surge on Study Data, GSK's Vaccine Study Fails & More
Terns Pharmaceuticals and Summit Therapeutics are in the spotlight following positive updates on key candidates.
| Ticker |
Sentiment |
Impact |
|
IMVT
|
Neutral
|
16 %
|
|
TERN
|
Neutral
|
29 %
|
|
RLAY
|
Neutral
|
13 %
|
|
GSK
|
Neutral
|
13 %
|
|
SMMT
|
Neutral
|
19 %
|
